AVOPLACEL
UNII 79NT7I8J0C
Substance Identification & Data
This profile provides standardized clinical and technical data for Avoplacel, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 79NT7I8J0C.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
79NT7I8J0C
N/A
N/A
Detailed Substance Profile
Preferred Name
AVOPLACEL
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
10883
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
HI-182
Identifier assigned by the United States Adopted Names Council.
Substance Type
structurallyDiverse
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
ITIS TSN
180092
Taxonomic Serial Number for species identified in the Integrated Taxonomic Information System.
NCBI Taxonomy
9606
Unique numeric identifier used to specify biological species in the NCBI database.
Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Avoplacel. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.
FDA Official Name
AVOPLACEL
Common Names & Synonyms
AVOPLACEL [INN]
AVOPLACEL [USAN]
HUMAN CULTURE EXPANDED ALLOGENIC MESENCHYMAL-LIKE ADHERENT STROMAL CELLS FOR CELL-BASED THERAPY. CELLS ARE OF FETAL ORIGIN AND DERIVED FROM PLACENTAE OF HEALTHY DONORS FOLLOWING A CESAREAN SECTION. CELLS EXPRESS CELL SURFACE MARKERS CD29, CD73, AND CD105 AND SECRETETHE FACTORS IL-6, IL-8 AND MCP-1
